NCT06628297 · NOT YET RECRUITING

Comparison of Differencens in VO2-max, Perfusion of the Heart and Brain and Cognitive Performance Between Patients with Type 2 Diabetes and Healthy Age Matched Controls.

This study compares people with type 2 diabetes to healthy people of the same age. Researchers use PET scans to measure blood flow in the heart and brain, along with fitness (VO2-max) and thinking tests. They want to know if small blood vessel problems link to weaker fitness and cognition. No phase is listed. It is an observational comparison, not a treatment test.

Eligibility criteria

Inclusion Criteria for the patients with type 2 diabetes:
Diabetes type II diagnose with one of the following:
* Duration over 5 years
* Moderate microalbuminuria
* Non-proliferative diabetic retinopathy
  * Speaks and understands Danish (required for reliable cognitive testing)
  * Able to provide informed and written consent
Exclusion Criteria or the patients with type 2 diabetes:
Moderate to high intensity training >1 times/week.
* Previous AMI, atrial fibrillation, significant cardiac valve disease, HFrEF (LVEF \<45%), asthma.
* Previous stroke or significant neurological disease including cognitive dysfunction.
* Ongoing depression.
* Hypothyroidism
* Unable or unwilling to participate in training, e.g., due to injury, arthrosis or lung disease.
Inclusion Criteria for the healthy age-matched controls:
* Age > 60 years
* No diagnosis of T2D according to WHO\'s criteria.
* Speaks and understands Danish (required for reliable cognitive testing)
* Able to provide informed and written consent
Exclusion Criteria for the healthy age-matched controls:
* Moderate to high intensity training >2 times/week.
* Previous AMI, atrial fibrillation, significant cardiac valve disease, HFrEF (LVEF \<45%), asthma.
* Previous stroke or significant neurological disease including cognitive dysfunction.
* Ongoing depression.
* Hypothyroidism
* Unable or unwilling to participate in training, e.g., due to injury, arthrosis or lung disease.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2024-10-04

View full record on ClinicalTrials.gov

All APOE4 clinical trials